Amsterdam University Medical Centre

Amsterdam 1105 AZ

3 studies enrolling now · 9 studies all time

What they study most

Bleeding, Chronic Graft-versus-host-disease, Follicular Lymphoma, Hypertension, Hypertension, Essential, Hypertension, Systolic, Lung Injury, Marginal Zone Lymphoma, Metastatic Cholangiocarcinoma, Neonatal Thrombocytopenia, Non-segmental Vitiligo, Preterm Birth

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia — Recruiting now
• Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) — Completed
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) — Completed
• Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo — Completed